Article

BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism

medRxiv · 2023 · Zhang, Z.; Liao, Q.; Pan, T.; Yu, L.; Luo, Z.; Su, S.; Liu, S.; Hou, M.; Li, Y.; Damba, T.; Liang, Y.; Zhou, L.

Key facts

Title BATF relieves hepatic steatosis by inhibiting PD1 and promoting energy metabolism
First author Zhang, Z.; Liao, Q.; Pan, T.; Yu, L.; Luo, Z.; Su, S.; Liu, S.; Hou, M.; Li, Y.; Damba, T.; Liang, Y.; Zhou, L.
Journal medRxiv
Published Jul 4, 2023
DOI 10.1101/2023.04.18.537352
Devices mentioned BK110039, DEN000008, K022086, K973350, K990827
Product codes mentioned JCI, KIP, KIT, MVU, NDS, NJT, JLX, KQP, PCA

At a glance

  • 1–9 FDA submissions mentioned
  • 1–9 Product codes mentioned

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About Literature

Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.

Source: Publisher and PubMed metadata; device mentions identified by Orca1

Browse all Literature